SARS-CoV-2 PLpro-IN-2
SARS-CoV-2 PLpro-IN-2 (Compound 12) is a highly selective SARS-CoV-2 papain-like protease (PLpro) inhibitor of (IC50=0.06 μM) . SARS-CoV-2 PLpro-IN-2 inhibits viral replication and immune evasion. SARS-CoV-2 PLpro-IN-2 exhibits antiviral efficacy in HeLa-ACE2 cells (EC50=2.9 μM) . SARS-CoV-2 PLpro-IN-2 is promising for research of COVID-19[1].
Product Specifications
CAS Number
[1581755-42-1]
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
C[C@@H](N1CCC(C(NCC2=CC=C(Cl)C=C2)=O)CC1)C3=CC=CC4=CC=CC=C43
Molecular Formula
C25H27ClN2O
Molecular Weight
406.95
References & Citations
[1]Gawriljuk VO, et al. Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PLpro) Inhibitors. ACS Omega. 2025 Sep 11;10 (37) :42711-42724.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15283988 1 Vial
Lentiviral mouse Alpk1 shRNA (UAS) - Lentiviral mouseAlpk1 shRNA (UAS, GFP) (25)
Ask
View Details GTR15138654 1 Vial
Lentiviral mouse Vmn1r219 shRNA (UAS) - Lentiviral mouse Vmn1r219 shRNA (UAS) (100)
Ask
View Details